Anesthetic management of a patient with congenital insensitivity to pain with anhidrosis by coadministration of remifentanil

  • Takeuchi Y
  • Fujita Y
  • Shimomura T
  • et al.
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND: Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive disease characterized by unexplained fever, systemic insensitivity to pain, anhidrosis, and mental distress. Anesthetic management is challenging because autonomic dysfunction can induce perioperative complications. Only a few reports of anesthetic management of CIPA patients have been published. We herein present a case of successful management of the same patient on two occasions using small doses of fentanyl and remifentanil. CASE PRESENTATION: A 37-year-old man with CIPA underwent two orthopedic operations. We were able to balance the dose of remifentanil to avoid the extremes of hyperalgesia when the dose is too low and shivering when the dose is too high. CONCLUSION: To our knowledge, no reports have described the anesthetic management of CIPA patients with remifentanil. We consider anesthetic management with coadministration of remifentanil to be potentially useful for such patients.

Cite

CITATION STYLE

APA

Takeuchi, Y., Fujita, Y., Shimomura, T., Kurokawa, S., Noguchi, H., & Fujiwara, Y. (2018). Anesthetic management of a patient with congenital insensitivity to pain with anhidrosis by coadministration of remifentanil. JA Clinical Reports, 4(1). https://doi.org/10.1186/s40981-018-0208-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free